Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal hyoscine butyl bromide for cervical ripening before hysteroscopy
IRCT20190929044920N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hyoscine butylbromide in endometrial polyp, endometrial hyperplasia (EH), Fibromyoma (LM) and 2 more, sponsored by Zahedan University of Medical Sciences. Started Oct 2019; status: completed.
02
Drugs
hyoscine butylbromide
03
Conditions
endometrial polypendometrial hyperplasia (EH)Fibromyoma (LM)menstrual disordersNoninflammatory disorder of uterus
Beyond the preview
Go deeper on IRCT20190929044920N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190929044920N1.